In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial

Despite successful introduction of NK-based cellular therapy in the treatment of myeloid leukemia, the potential use of NK alloreactivity in solid malignancies is still elusive. We performed a phase I clinical trial to assess the safety and efficacy of in situ delivery of allogeneic NK cells combine...

Full description

Bibliographic Details
Main Authors: O. Adotevi, Y. Godet, J. Galaine, Z. Lakkis, I. Idirene, J. M. Certoux, M. Jary, R. Loyon, C. Laheurte, S. Kim, A. Dormoy, F. Pouthier, C. Barisien, F. Fein, P. Tiberghien, X. Pivot, S. Valmary-Degano, C. Ferrand, P. Morel, E. Delabrousse, C. Borg
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:OncoImmunology
Subjects:
adoptive cell transfer
cetuximab
intrahepatic infusion
nk cell
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1424673

Internet

http://dx.doi.org/10.1080/2162402X.2018.1424673

Similar Items